{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:26:10Z","timestamp":1784679970560,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13555-020-00353-3","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T12:02:47Z","timestamp":1579608167000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events"],"prefix":"10.1007","volume":"10","author":[{"given":"Yoo Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bioorg.2017.02.011","volume":"71","author":"A Jameera Begam","year":"2017","unstructured":"Jameera Begam A, Jubie S, Nanjan MJ. Estrogen receptor agonists\/antagonists in breast cancer therapy: a critical review. Bioorg Chem. 2017;71:257\u201374.","journal-title":"Bioorg Chem"},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clbc.2017.05.014","volume":"18","author":"NJ Robert","year":"2018","unstructured":"Robert NJ, Denduluri N. Patient case lessons: endocrine management of advanced breast cancer. Clin Breast Cancer. 2018;18:192\u2013204.","journal-title":"Clin Breast Cancer"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10549-007-9518-7","volume":"106","author":"K Jhaveri","year":"2007","unstructured":"Jhaveri K, Halperin P, Shin SJ, Vahdat L. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Res Treat. 2007;106:315\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clim.2008.07.001","volume":"129","author":"M Wong","year":"2008","unstructured":"Wong M, Grossman J, Hahn BH, La Cava A. Cutaneous vasculitis in breast cancer treated with chemotherapy. Clin Immunol. 2008;129:3\u20139.","journal-title":"Clin Immunol"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1078155213480535","volume":"20","author":"A Digklia","year":"2014","unstructured":"Digklia A, Tzika E, Voutsadakis IA. Cutaneous leukocytoclastic vasculitis associated with letrozole. J Oncol Pharm Pract. 2014;20:146\u20138.","journal-title":"J Oncol Pharm Pract"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijscr.2015.09.024","volume":"16","author":"P Pathmarajah","year":"2015","unstructured":"Pathmarajah P, Shah K, Taghipour K, Ramachandra S, Thorat MA, Chaudhry Z, Patkar V, Peters F, Connor T, Spurrell E, Tobias JS, Vaidya JS. Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: first report of a case in the UK. Int J Surg Case Rep. 2015;16:77\u201380.","journal-title":"Int J Surg Case Rep"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/ard.2004.023150","volume":"64","author":"H Shoda","year":"2005","unstructured":"Shoda H, Inokuma S, Yajima N, Tanaka Y, Setoguchi K. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment. Ann Rheum Dis. 2005;64:651\u20132.","journal-title":"Ann Rheum Dis"},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1468-3083.2010.03803.x","volume":"25","author":"S Santoro","year":"2011","unstructured":"Santoro S, Santini M, Pepe C, Tognetti E, Cortelazzi C, Ficarelli E, De Panfilis G. Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis. J Eur Acad Dermatol Venereol. 2011;25:596\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jare.2016.04.001","volume":"7","author":"G Zarkavelis","year":"2016","unstructured":"Zarkavelis G, Kollas A, Kampletsas E, Vasiliou V, Kaltsonoudis E, Drosos A, Khaled H, Pavlidis N. Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: a review. J Advert Res. 2016;7:719\u201326.","journal-title":"J Advert Res"},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5606\/ArchRheumatol.2014.3429","volume":"29","author":"G Pokhai","year":"2014","unstructured":"Pokhai G, Buzzola R, Abrudescu A. Letrozole-induced very early systemic sclerosis in a patient with breast cancer: a case report. Arch Rheumatol. 2014;29:126\u20139.","journal-title":"Arch Rheumatol"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3889\/oamjms.2018.026","volume":"6","author":"U Wollina","year":"2018","unstructured":"Wollina U, Sch\u00f6nlebe J, Heinig B, Tchernev G, Fran\u00e7a K, Lotti T. Segmental erythema multiforme-like drug eruption by aromatase inhibitor anastrozole\u2014first case report and another example of an immunocompromised district. Open Access Maced J Med Sci. 2018;6:79\u201381.","journal-title":"Open Access Maced J Med Sci"},{"issue":"7","key":"353_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D339J317BW","volume":"15","author":"T Bremec","year":"2009","unstructured":"Bremec T, Demsar J, Luzar B, Pavlovi\u0107 MD. Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor. Dermatol Online J. 2009;15(7):14.","journal-title":"Dermatol Online J"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/annonc\/mdn687","volume":"20","author":"G Mustacchi","year":"2009","unstructured":"Mustacchi G, Mansutti M, Sacco C, Barni S, Farris A, Cazzaniga M, Cozzi M, Dellach C. Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study. Ann Oncol. 2009;20:655\u20139.","journal-title":"Ann Oncol"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3899\/jrheum.080648","volume":"36","author":"J Chao","year":"2009","unstructured":"Chao J, Parker BA, Zvaifler NJ. Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis. J Rheumatol. 2009;36:1087\u20138.","journal-title":"J Rheumatol"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000497469","volume":"11","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Yamashita C, Hinogami H, Shirai H, Yamamura J, Ito R. Localized cutaneous adverse event induced by anastrozole as adjuvant treatment for breast cancer: a case report. Case Rep Dermatol. 2019;11:57\u201363.","journal-title":"Case Rep Dermatol"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1365-2133.2007.08367.x","volume":"158","author":"M Trancart","year":"2008","unstructured":"Trancart M, Cavailhes A, Balme B, Skowron F. Anastrozole-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2008;158:628\u20139.","journal-title":"Br J Dermatol"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/030089160609200103","volume":"92","author":"C Gennatas","year":"2006","unstructured":"Gennatas C, Michalaki V, Carvounis E, Psychogios J, Poulakaki N, Katsiamis G, Voros D, Kouloulias V, Mouratidou D, Tsavaris N. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO). Tumori. 2006;92:13\u20137.","journal-title":"Tumori."},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5301\/tj.5000376","volume":"101","author":"L Moscetti","year":"2015","unstructured":"Moscetti L, Agnese Fabbri M, Sperduti I, Fabrizio N, Frittelli P, Massari A, Pompei L, D\u2019Auria G, Pofi E, Ruggeri EM. Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment? Tumori. 2015;101:469\u201373.","journal-title":"Tumori"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0190-9622(98)70390-1","volume":"39","author":"FM Williams","year":"1998","unstructured":"Williams FM, Cohen PR, Arnett FC. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. J Am Acad Dermatol. 1998;39:359\u201362.","journal-title":"J Am Acad Dermatol"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/j.1468-3083.2009.03345.x","volume":"23","author":"V Ruocco","year":"2009","unstructured":"Ruocco V, Brunetti G, Puca RV, Ruocco E. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol. 2009;23:1364\u201373.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00353-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-020-00353-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00353-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T12:34:27Z","timestamp":1722342867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-020-00353-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00353-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}